EFFECTIVENESS OF A BIOLOGICAL PROSTHESIS IN THE TREATMENT OF TRAUMATIC FEMORAL ARTERY INJURIES

Highlights

The prevalence of vascular injuries during military engagements can reach 20%. In the thigh, vascular injuries are the second most frequent type of injury. Vascular replacement using a graft is required in case of a femoral artery injury with length of more than 10 cm. If autologous blood vessels are not available for replacement, specialists resort to using a synthetic prosthesis. Selection of an appropriate prosthesis remains a priority for vascular surgeons.

Aim. To evaluate the outcome of vascular replacement using a biological prosthesis derived from bovine internal thoracic arteries for the treatment of femoral artery injuries.

Material and methods. The study involved 30 patients with femoral artery injuries. The analysis focused on the indicators of comprehensive examination and treatment of these patients, who were divided into 2 statistically homogeneous groups of 15 people each. In the first group, a biological prosthesis derived from bovine internal thoracic artery was used to replace the artery, and in the second group, a large subcutaneous vein was used. The results of treatment were evaluated by the number of postoperative complications, the durability of grafts and the quality of life of patients.

Results. There were no fatal cases. In the first group, 6 (40%) patients suffered postoperative complications, and in the second group – in 5 (33.3%) patients. After 5 years, 12 (80%) grafts remained functioning in the first group, and 13 (86.7%) grafts in the second group. The physical component of the health of patients in the first group was equal to 60.6 ± 3.2, in the second group – 62.5 ± 3.4, and the psychological component of health 58.7 ± 2.8, and 59.5 ± 3.1, respectively. There was no statistical reliability between the indicators of the groups (p > 0.05).

Conclusion. Biological prosthesis derived from bovine internal thoracic arteries for the treatment of femoral artery injuries is quite effective.

1. Lazarenko V.A., Bobrovskaya E.A., Ivanov I.S., Lipatov V.A., Mishustin V.N., Godunova E.I. Immune status in developing restenosis in patients with occlusive-stenotic lesion of the femoral-popliteal arterial segment after femoral-popliteal bypass surgery. Humans and their health. 2023;26 (2):4-12. doi:10.21626/vestnik/2023-2/01. (In Russ)

2. Imran H.M., Hyder O.N., Soukas P.A. Efficacy and safety of adjunctive drug-coated ballon therapy in endovascular treatment of common femoral artery disease. Cardiovascular Revascularization Medicine. 2019;20 (3): 210–214. doi:10.1016j.carrev./2018.06.018

3. Pastromas G., Katsanos K., Krokidis M., Karnabatidis D., Spiliopoulos S. Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries. The Scientific World Journal. 2014; 2014 (695402): 1-6. doi:10.1155/2014/695402

4. Conte M.S. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia. J. Vasc. Surg. 2010; (51) (Suppl. S): 69-75.

5. Svetlikov A.V., Gamzatov T.H., Kebryakov A.V., Tishkov A.V., Margariants N.B., Hardikov I.E., Galkin P.A., Shapovalov A.S., Lukin S.V., Melnikov V.M., Khubulava G.G., Kashchenko V.A., Ratnikov V.A., Gurevich V.S. Surgical tactics of treatment of chronic ischemia in patients with atherosclerotic lesion of the deep femoral artery and occlusion of the superficial femoral artery. Angiology and vascular surgery. The journal named after Academician A.V. Pokrovsky. 2023;29 (2): 61-72. doi:10.33029/1027-6661-2023-29-2-61-72. (In Russ)

6. Elsharkawi M., Elkassaby M., McVeigh N., et al. Clinical outcomes from profundoplasty performed as a sole procedure for revascularizatiom in critically ischaemic limbs. Vascular. 2021; 29 (3): 396–403. doi:10.1177/1708538120963901

7. National recommendations for the diagnosis and treatment of diseases of the arteries of the lower extremities. M: Association of cardiovascular surgeons of Russia russian society of angiologists and vascular surgeons russian society of surgeons russian society of cardiology russian association of endocrinologists – 89c. (In Russ)

8. Balasundaram N., Whitrock J.N., Braet D.J., et al. Importance of the profunda femoris upon patency following aortoiliae procedures. Journal of Vascular Surgery. 2022; 76 (1): 180–187. Doi:10.1016/j.jvs.2022.02.043.

9. Fomin V.S., Sazonov A.B., Kitachev K.V., Yakovlev N.N., Zelenin V.V., Kudryavtsev O.I.,Gulmetov P.E., Suvorov S.A., Dzhumaeva A.A., Al-Hasanat M.M., Hong Kimhen, Hubulava G.G. The choice of the method of revascularization of the lower extremities in occlusive lesion arteries of the femoral-popliteal segment. Angiology and vascular surgery. The journal named after Academician A.V. Pokrovsky. 2023;29 (1): 109-114 doi:10.33029/1027-6661-2023-29-1-109-114. (In Russ)

10. Bokeria L.A., Arakelyan V.S., Papitashvili V.G., Tsurtsumiya Sh.Sh. Results of isolated profundoplasty in comparison with distal bypass surgery in patients with diabetes mellitus and trophic ulcers. Kuban Scientific Medical Bulletin. 2020; 27 (2):38-48 doi:10.25207/1608-6228-2020-27-2-38-48. (In Russ)

11. Khorev N.G., Kotov V.I., Konkova V.O., //Some clinical and laboratory predictors of structural changes in biological shunt after femoral-popliteal bypass surgery.//Outpatient surgery. 2022;19 (1):44-49. doi:10.21518/1995-1477-2022-19-1-44-49. (In Russ)

12. Sukovatykh B.S., Sidorov D.V., Sukovatykh M.B. Reaction of connective tissue of arterial and venous walls to implantation of synthetic and biological grafts. Angiology and Vascular Surgery. 2019;25(1):46-51. Available at: https://www.angiolsurgery.org/maga. (In Russ)